United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
499.73
-1.54 (-0.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed

United Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,3111,3351,195984.8727.3475.8
Depreciation & Amortization
91.585.672.553.251.349.9
Asset Writedown & Restructuring Costs
-21.7-3.611.2132.6
Loss (Gain) From Sale of Investments
38.9----5.4-90.3
Stock-Based Compensation
155.4147.714439.1106.8138.5
Other Operating Activities
181.778-88.4-69.352.565.9
Change in Accounts Receivable
69-70.9-0.4-58.5-21.7-41.3
Change in Inventory
-91.8-52.6-46.9-13.6-13.4-7.5
Change in Accounts Payable
37.797.942.757.144.5-12.5
Change in Other Net Operating Assets
-108.1-80.98.5-18.4-150.6-112.9
Operating Cash Flow
1,6851,5611,327978802.5598.2
Operating Cash Flow Growth
22.89%17.64%35.70%21.87%34.15%-20.84%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-592.2-520.5-246.5-230.4-138.8-120.8
Cash Acquisitions
----89.2--
Sale (Purchase) of Intangibles
-5.5-5.5----
Investment in Securities
1,349-14.9692.2-377-676.2-366.1
Other Investing Activities
-7-10.4-28.5-233.5-
Investing Cash Flow
744.5-551.3417.2-719.6-811.5-486.9

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-200--800-
Long-Term Debt Repaid
--500-400-100-800-
Net Debt Issued (Repaid)
--300-400-100--
Issuance of Common Stock
343.7183.1160.1104.694.355.6
Repurchase of Common Stock
-2,560-1,022-1,012-13.8-11.4-10.8
Other Financing Activities
-3.4-11.5-2.7-2.7-7.5-
Financing Cash Flow
-2,220-1,150-1,255-11.975.444.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
210.1-140.1489.5246.566.4156.1

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,0931,0411,081747.6663.7477.4
Free Cash Flow Growth
2.05%-3.69%44.54%12.64%39.02%-31.45%
Free Cash Flow Margin
34.65%32.70%37.55%32.12%34.28%28.32%
Free Cash Flow Per Share
23.3021.7322.2815.0413.6910.09
Levered Free Cash Flow
557.14583.2834.08613.49506.28406.69
Unlevered Free Cash Flow
564.64595.39860.89650.55526.53418.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7.713.540.25629.116.2
Cash Income Tax Paid
161.9313.3400.6332.5275.7153.3
Change in Working Capital
-93.2-106.53.9-33.4-141.2-174.2
SEC Filings: 10-K · 10-Q